Similarly, our findings, along with those of Vakili-Samiani et al. (2021) [27] in Mexico City, imply that elevated expression of IL-35 and IL-37 may be responsible for the down-regulation of inflammation in active inflammatory bowel disease (IBD) patients. This evidence concerns the gene IL37 and inflammatory bowel disease.